Andree, M., J. M. Seeger, S. Schüll, O. Coutelle, D. Wagner-Stippich, K. Wiegmann, C. M. Wunderlich, K. Brinkmann, P. Broxtermann, A. Witt, M. Fritsch, P. Martinelli, H. Bielig, T. Lamkemeyer, E. I. Rugarli, T. Kaufmann, A. Sterner-Kock, F. T. Wunderlich, A. Villunger, L. M. Martins, M. Krönke, T. A. Kufer, O. Utermöhlen and H. Kashkar: BID-dependent release of mitochondrial SMAC dampens XIAP-mediated immunity against Shigella. In: EMBO Journal 33, 19, 2171-2187 (2014).
doi: 10.15252/embj.201387244
Gruber, S., B. Straub, P. J. Ackermann, C. M. Wunderlich, J. Mauer, J. M. Seeger, H. Büning, L. Heukamp, H. Kashkar, P. Schirmacher, J. C. Brüning and F. T. Wunderlich: Obesity promotes liver carcinogenesis via Mcl-1 stabilization independent of IL-6Rα signaling. In: Cell Reports 4, 4, 669-680 (2013).
doi: 10.1016/j.celrep.2013.07.023
Gruber, S., B. Straub, P. J. Ackermann, C. M. Wunderlich, J. Mauer, J. M. Seeger, H. Büning, L. Heukamp, H. Kashkar, P. Schirmacher, J. C. Brüning and F. T. Wunderlich: Obesity promotes liver carcinogenesis via Mcl-1 stabilization independent of IL-6Rα signaling. In: Cell Reports 4, 4, 669-680 (2013).
doi: 10.1016/j.celrep.2013.07.023
Sos, M. L., S. Fischer, R. Ullrich, M. Peifer, J. M. Heuckmann, M. Koker, S. Heynck, I. Stueckrath, J. Weiss, F. Fischer, K. Michel, A. Goel, L. Regales, K. A. Politi, S. Perera, M. Getlik, L. C. Heukamp, S. Ansen, T. Zander, R. Beroukhim, H. Kashkar, K. M. Shokat, W. R. Sellers, D. Rauh, C. Orr, K. P. Hoeflich, L. Friedman, K.-K. Wong, W. Pao and R. K. Thomas: Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer. In: Proceedings of the National Academy of Sciences of the United States of America 106, 18351-18356 (2009).
doi: 10.1073/pnas.0907325106
Sos, M. L., S. Fischer, R. Ullrich, M. Peifer, J. M. Heuckmann, M. Koker, S. Heynck, I. Stückrath, J. Weiss, F. Fischer, K. Michel, A. Goel, L. Regales, K. A. Politi, S. Perera, M. Getlik, L. C. Heukamp, S. Ansén, T. Zander, R. Beroukhim, H. Kashkar, K. M. Shokat, W. R. Sellers, D. Rauh, C. Orr, K. P. Hoeflich, L. Friedman, K.-K. Wong, W. Pao and R. K. Thomas: Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer. In: Proceedings of the National Academy of Sciences of the United States of America 106, 43, 18351-18356, Seq. No.: 1 (2009).
url: http://www.pnas.org/content/106/43/18351.abstract
Sos, M. L., S. Fischer, R. Ullrich, M. Peifer, J. M. Heuckmann, M. Koker, S. Heynck, I. Stueckrath, J. Weiss, F. Fischer, K. Michel, A. Goel, L. Regales, K. A. Politi, S. Perera, M. Getlik, L. C. Heukamp, S. Ansen, T. Zander, R. Beroukhim, H. Kashkar, K. M. Shokat, W. R. Sellers, D. Rauh, C. Orr, K. P. Hoeflich, L. Friedman, K.-K. Wong, W. Pao and R. K. Thomas: Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer. In: Proceedings of the National Academy of Sciences of the United States of America 106, 18351-18356 (2009).
doi: 10.1073/pnas.0907325106
Sos, M. L., S. Fischer, R. Ullrich, M. Peifer, J. M. Heuckmann, M. Koker, S. Heynck, I. Stueckrath, J. Weiss, F. Fischer, K. Michel, A. Goel, L. Regales, K. A. Politi, S. Perera, M. Getlik, L. C. Heukamp, S. Ansen, T. Zander, R. Beroukhim, H. Kashkar, K. M. Shokat, W. R. Sellers, D. Rauh, C. Orr, K. P. Hoeflich, L. Friedman, K.-K. Wong, W. Pao and R. K. Thomas: Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer. In: Proceedings of the National Academy of Sciences of the United States of America 106, 18351-18356 (2009).
doi: 10.1073/pnas.0907325106
Sos, M. L., M. Koker, B. A. Weir, S. Heynck, R. Rabinovsky, T. Zander, J. M. Seeger, J. Weiss, F. Fischer, P. Frommolt, K. Michel, M. Peifer, C. Mermel, L. Girard, M. Peyton, A. F. Gazdar, J. D. Minna, L. A. Garraway, H. Kashkar, W. Pao, M. Meyerson and R. K. Thomas: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR. In: Cancer Research 69, 8, 3256-3261, Seq. No.: 1 (2009).
url: http://dx.doi.org/10.1158/0008-5472.CAN-08-4055
Sos, M., M. Koker, B. Weir, S. Heynck, R. Rabinovsky, T. Zander, J. M. Seeger, J. Weiss, F. Fischer, P. Frommolt, K. Michel, M. Peifer, C. Mermel, L. Girard, M. Peyton, A. F. Gazdar, J. D. Minna, L. A. Garraway, H. Kashkar, W. Pao, M. Meyerson and R. K. Thomas: PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR. In: Cancer Research 69, 8, 3256-3261 (2009).
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.